Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05454267 · ClinicalTrials.gov registry record
Early Detection of Vaping-related Vascular Diseases
A clinical trial of Vaping and Blood Vessel Injury, sponsored by University of Miami.
- Recruiting
- Registry status
- 90
- Enrollment target
- 1
- Study location
NCT05454267 is a study of Vaping and Blood Vessel Injury that is actively recruiting participants, run by University of Miami. The registered enrollment target is 90 participants, below the 756-participant average among 18 other Vaping trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05454267, a study of Vaping and Blood Vessel Injury, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine how vaping affects blood vessels, in particular if early damage occurs in the lung vessels.
Conditions Studied
Study Locations (1)
Florida
- University of Miami Health System - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-09-12 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05454267
The ClinicalTrials.gov registry entry for NCT05454267 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 756-participant average among 18 other Vaping trials with a reported enrollment target (88% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Vaping appearing as the primary indexed condition, and to 0 interventions.
NCT05454267 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05454267 about?
NCT05454267 is a clinical study titled "Early Detection of Vaping-related Vascular Diseases". The purpose of this study is to determine how vaping affects blood vessels, in particular if early damage occurs in the lung vessels.
What is the current status of trial NCT05454267?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2022-09-12. Estimated completion is 2026-12-31.
What conditions does trial NCT05454267 study?
This clinical trial studies the following conditions: Vaping, Blood Vessel Injury.
Who is sponsoring clinical trial NCT05454267?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05454267 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaping
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
RECRUITING · NA
-
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
RECRUITING · NA
-
A Trial of Varenicline for E-cigarette Cessation
RECRUITING · Phase 2
-
Vape Use Among Younger & Older Smokers
RECRUITING
-
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
RECRUITING · NA
-
Behavioral Intervention for Youth to Promote Vaping Cessation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.